Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes (Q35142616)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes |
scientific article |
Statements
1 reference
Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes (English)
1 reference
Sergio Giralt
1 reference
Koen van Besien
1 reference
Rangesh Kunavakkam
1 reference
Gaby Rondon
1 reference
Marcos De Lima
1 reference
Andrew Artz
1 reference
Betul Oran
1 reference
1 May 2009
1 reference
1 reference
15
1 reference
5
1 reference
610-617
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference